Cover Image

Iterative surgical resections in non-small cell lung cancer

Saved in:

Bibliographic Details
Main Authors:	Ahmet Ucvet (Author), Serkan Yazgan (Author), Ozgur Samancilar (Author), Soner Gursoy (Author), Ahmet Emin Erbaycu (Author), Berna Komurcuoglu (Author)
Format:	Book
Published:	Termedia Publishing House, 2022-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Emergency pulmonary resection in massive hemoptysis: analysis of 39 patients
by: Serkan Yazgan, et al.
Published: (2022)

Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer
by: Qiuyuan Wen, et al.
Published: (2019)

Role of Neoadjuvant Immune Checkpoint Inhibitors in Resectable Non-Small Cell Lung Cancer
by: Ivy Riano, et al.
Published: (2023)

Wedge resection and segmentectomy in patients with stage I non-small cell lung carcinoma
by: Konstantinos Reveliotis, et al.
Published: (2014)

Osimertinib as Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: A Case Series
by: Yan Hu, et al.
Published: (2022)

Evidence for the evolving role of neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancer
by: Thomas Hansen, et al.
Published: (2024)

ALK, ROS1 and EGFR status of lung cancers in the Aegean Region of Turkey
by: Gulden Diniz, et al.
Published: (2022)

Prognostic Value of CXCL12 in Non-Small Cell Lung Cancer Patients Undergoing Tumor Resection
by: Yurie Kogue, et al.
Published: (2023)

Effect of Insurance Type on Stage at Presentation, Surgical Approach, Tumor Recurrence and Cancer-Specific Survival in Resectable Non-Small Lung Cancer Patients
by: Siwachat S, et al.
Published: (2020)

Clinical and surgical implications of EGFR mutations in non-small cell lung cancer
by: M. Yoon, et al.
Published: (2016)

Clinical and surgical-pathological staging in early non-small cell lung cancer
by: Ioannis Koukis, et al.
Published: (2013)

Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer: current status and perspectives
by: Luis A. Godoy, et al.
Published: (2023)

Neoadjuvant targeted therapy for resectable EGFR-mutant non-small cell lung cancer: Current status and future considerations
by: Wenliang Liu, et al.
Published: (2022)

Advancing neoadjuvant therapies in resectable non-small cell lung cancer: implications for novel treatment strategies and biomarker discovery
by: Hyein Jeon, et al.
Published: (2024)

High LARGE1 Expression May Predict Benefit from Adjuvant Chemotherapy in Resected Non-Small-Cell Lung Cancer
by: Liu Y, et al.
Published: (2021)

Osimertinib in the treatment of resected EGFR-mutated non-small cell lung cancer: a cost-effectiveness analysis in the United States
by: Gengwei Huo, et al.
Published: (2024)

Comparative study of the PD-L1 expression and CD8+ tumor-infiltrating lymphocyte between surgically resected and matched re-biopsy specimens in recurrent non-small cell lung cancer
by: Shimizu K, et al.
Published: (2019)

Evaluation of All Surgical Margins in Pancreatic Resection Specimens by Proper Grossing Techniques: Surgical Pathology Experience of 285 Cases
by: Özgür EKİNCİ
Published: (2018)

Specific TCR profiles predict clinical outcome of adjuvant EGFR-TKIs for resected EGFR-mutant non-small cell lung cancer
by: Si-Yang Maggie Liu, et al.
Published: (2023)

Case Report: Pathological Complete Response to Neoadjuvant Alectinib in a Patient With Resectable ALK-Positive Non-Small Cell Lung Cancer
by: Yan Hu, et al.
Published: (2022)

Sampling versus systematic full lymphatic dissection in surgical treatment of non-small cell lung cancer
by: Georgios Koulaxouzidis, et al.
Published: (2013)

Underwater Endoscopic Mucosal Resections of Non-ampullary Small Duodenal Tumors
by: Jung Wook Lee, et al.
Published: (2022)

Asymptomatic Congenital Lung Malformations: Timing of Resection Does Not Affect Adverse Surgical Outcomes
by: Vincent Duron, et al.
Published: (2020)

Naples Prognostic Score as an Independent Predictor of Survival Outcomes for Resected Locally Advanced Non-Small Cell Lung Cancer Patients After Neoadjuvant Treatment
by: Zou Z, et al.
Published: (2023)

Epigenetics in non-small cell lung carcinomas
by: Irlanda Peralta-Arrieta, et al.
Published: (2019)

Iterative Upgrading of Small Molecular Tyrosine Kinase Inhibitors for EGFR Mutation in NSCLC: Necessity and Perspective
by: Jing Zhu, et al.
Published: (2021)

Comparison of survival results of patients with T0 and T1-2-3 in pathological T staging in patients with non-small cell lung cancer who underwent surgery after neoadjuvant treatment
by: Tayfun Kermenli, et al.
Published: (2020)

Sintilimab for the treatment of non-small cell lung cancer
by: Lin Zhang, et al.
Published: (2022)

Chemoresistance factors in non-small cell lung cancer
by: А. I. Shevchenko, et al.
Published: (2016)

Non-Small-Cell Lung Cancer. Unusual Small Bowel Metastasis with Invagination
by: Miguel Ángel Serra Valdés, et al.
Published: (2017)

Non-Small-Cell Lung Cancer. Unusual Small Bowel Metastasis with Invagination
by: Miguel Ángel Serra Valdés, et al.
Published: (2017)

Effect of postoperative radiotherapy on survival in patients with completely resected and pathologically confirmed stage N2 non-small-cell lung cancer: a systematic review and meta-analysis
by: Lin Wang, et al.
Published: (2023)

Open resections for congenital lung malformations
by: Mullassery Dhanya, et al.
Published: (2008)

Preoperative pulmonary evaluation for lung resection
by: Preety Mittal Roy
Published: (2018)

Current status of immunotherapy for non-small cell lung cancer
by: Tao Yang, et al.
Published: (2022)

PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY
by: A. V. Rudakova, et al.
Published: (2017)

Therapeutic Implications of PTEN in Non-Small Cell Lung Cancer
by: Zaid Sirhan, et al.
Published: (2023)

Inhaled Medicines for Targeting Non-Small Cell Lung Cancer
by: Arwa Omar Al Khatib, et al.
Published: (2023)

First line Immunotherapy for Non-Small Cell Lung Cancer
by: Nicola J. Nasser, et al.
Published: (2020)

The inhibitory effect of dihydroartemisinin on non-small cells lung cancer
by: Yan Li, et al.
Published: (2021)